{"id":"ginkgo-biloba-methylprednisolone","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Infection risk (immunosuppression)"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ginkgo biloba contains flavonoids and terpenoids that scavenge free radicals and improve microcirculation, while methylprednisolone is a corticosteroid that suppresses inflammatory cytokine production and reduces edema. Together, they target both oxidative stress and inflammatory pathways implicated in acute neurological injury or degeneration.","oneSentence":"This combination uses Ginkgo biloba's antioxidant and neuroprotective properties alongside methylprednisolone's anti-inflammatory and immunosuppressive effects to reduce neuroinflammation and promote recovery.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:47:27.349Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute spinal cord injury (Phase 3 trial context at Asan Medical Center)"}]},"trialDetails":[{"nctId":"NCT04192656","phase":"PHASE4","title":"The Effect of PAP on ISSHL Comorbided With OSA","status":"RECRUITING","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2019-11-01","conditions":"Sudden Hearing Loss, Obstructive Sleep Apnea","enrollment":102},{"nctId":"NCT02098330","phase":"PHASE3","title":"The Efficacy of Steroid Therapy in Vestibular Neuritis","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2014-03","conditions":"Vestibular Neuritis","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ginexin","Methylprednisolone"],"phase":"phase_3","status":"active","brandName":"Ginkgo biloba & Methylprednisolone","genericName":"Ginkgo biloba & Methylprednisolone","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination uses Ginkgo biloba's antioxidant and neuroprotective properties alongside methylprednisolone's anti-inflammatory and immunosuppressive effects to reduce neuroinflammation and promote recovery. Used for Acute spinal cord injury (Phase 3 trial context at Asan Medical Center).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}